| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/19/2004 | US20040033542 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 02/19/2004 | US20040033540 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 02/19/2004 | US20040033536 Methods for identifying and using insecticides |
| 02/19/2004 | US20040033535 Antibodies to OPGL |
| 02/19/2004 | US20040033533 Method of diagnosing metabolic bone diseases |
| 02/19/2004 | US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033236 Recombinant constructs of borrelia burgdorferi |
| 02/19/2004 | US20040033232 Methods and compositions for in vivo clearance of pathogens |
| 02/19/2004 | US20040033231 First domain comprising a PP14 polypeptide sequence and a second domain comprising a polypeptide sequence of the Fc region of an immunoglobulin protein; treatment of immune system diseases and disorders |
| 02/19/2004 | US20040033230 Breast tumor polypeptides, polynucleotides that encode them, antigen presenting cells that express them, and T cells that are specific for cells that express them. |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033225 Antitumor agents; monoclonal antibodies |
| 02/19/2004 | US20040033224 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration |
| 02/19/2004 | US20040033211 Antigen arrays for treatment of bone disease |
| 02/19/2004 | US20040033210 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor |
| 02/19/2004 | CA2497662A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | CA2495725A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 02/19/2004 | CA2495408A1 A method of immunomodulation |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2494319A1 Use of antibodies against a tumor-associated antigen |
| 02/19/2004 | CA2485548A1 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 02/19/2004 | CA2427693A1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 02/18/2004 | EP1389306A2 Method for detecting progredient chronic dementia, and corresponding peptides and detection reagents |
| 02/18/2004 | EP1389239A2 Methods and compositions for making emamectin |
| 02/18/2004 | EP1389236A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/18/2004 | EP0967995B1 Composition comprising immunoglobulin |
| 02/18/2004 | EP0817851B1 Dna encoding human papilloma virus type 18 |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | CN1475570A Cutin forming cell growth factor-2 |
| 02/18/2004 | CN1475568A New type human death resist protein, its coded sequence and use |
| 02/18/2004 | CN1475506A Fortified fusion protein FV-LDP-AE possessing angiopoiesis inhibiting and antitumour actions |
| 02/18/2004 | CN1475502A New withered induced protein, its coded sequence and use |
| 02/18/2004 | CN1475501A New type human bone marrow substrate cell source 1 type phosphoric acid enzyme inhibition factor, its coded sequence and use |
| 02/18/2004 | CN1475500A New type human marrow differentiation tagged object its coded sequence and use |
| 02/18/2004 | CN1475499A New type human cell signal related protein, its code sequence and use |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/17/2004 | WO2004006898A3 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693183 MURINE α (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 02/17/2004 | US6693177 Multiple chromatographic separations, neutralization and dialysis |
| 02/17/2004 | US6693176 Dmf10.167.4 produced by hybridoma cell line atcc no. pta-405 monoclonal antibody or antigen binding fragment |
| 02/17/2004 | US6693175 Detecting and treating bone disorder of humans |
| 02/17/2004 | US6693174 Nucleotide sequences coding fungicide for use in the prevention of fungal infections |
| 02/17/2004 | US6693171 ACPL polypeptides |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6693079 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693078 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6692964 Stimulating proliferating cell prior to introducing nucleic acid molecule |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692942 Single-chain polypeptides for targeted delivery of nucleic acids |
| 02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides |
| 02/17/2004 | US6692930 Immunoglobulin for use in the detection of preferential meats; for use in accurately labeling meats |
| 02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
| 02/17/2004 | US6692925 Determining if a substance inhibits tgf- beta / alk1 induced smad1 phosphorylation |
| 02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 |
| 02/17/2004 | US6692744 Betaglycan as an inhibin receptor and uses thereof |
| 02/17/2004 | US6692743 Apoptosis of naive human NK cells by crosslinking of their FcγRIIIa molecules with a rat IgG2b (LO-CD2a/BTI-322) or its IgG1 humanized monoclonal antibody |
| 02/17/2004 | US6692742 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/17/2004 | US6692740 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases |
| 02/17/2004 | US6692739 Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| 02/17/2004 | CA2143325C Cloning and expression of .beta.app-c100 receptor |
| 02/17/2004 | CA2112667C Monoclonal antibodies to putative hcv ns5 proteins and methods for using same |
| 02/17/2004 | CA2075288C Anthracycline-conjugates |
| 02/13/2004 | CA2397169A1 Targeted ligands |
| 02/12/2004 | WO2004013325A1 Method of detecting mouse interferon-producing cells |
| 02/12/2004 | WO2004013287A2 Antibodies against c3a receptor |
| 02/12/2004 | WO2004013278A2 Expression vectors |
| 02/12/2004 | WO2004013276A2 Novel tricistronic vectors and uses therefor |
| 02/12/2004 | WO2004013180A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | WO2004013174A1 Use of disease-associated gene |
| 02/12/2004 | WO2004013172A2 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 02/12/2004 | WO2004013171A2 Multi-subunit protein production system in transgenic insect |
| 02/12/2004 | WO2004013158A2 MUTANTS OF IgE PROTEINS AND USES THEREOF |
| 02/12/2004 | WO2004013157A2 REDUCING NgR-p75 MEDIATED BY INHIBITION OF AXON REGENERATION |
| 02/12/2004 | WO2004013151A2 Campylobacter glycans and glycopeptides |
| 02/12/2004 | WO2004012817A2 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs |
| 02/12/2004 | WO2004012768A1 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and/or a mtor inhibitor |
| 02/12/2004 | WO2004012767A1 Medicinal agent and method for curing erectile dysfunction |
| 02/12/2004 | WO2004012766A1 Method for correcting immune responses and medicinal agent |
| 02/12/2004 | WO2004012765A1 Medicinal agent and method for curing pathological syndrome associated to hemodiscrasia |
| 02/12/2004 | WO2004012764A1 Medicinal agent and method for curing prostate diseases |
| 02/12/2004 | WO2004012763A1 Modulation of mesenchymal cells via iga-receptors |
| 02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
| 02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
| 02/12/2004 | WO2003086041A3 Binding agents and their use in targeting tumor cells |
| 02/12/2004 | WO2003082329A3 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine |
| 02/12/2004 | WO2003078468A3 Use of an active substance that binds to cd28 for producing a pharmaceutical composition |
| 02/12/2004 | WO2003060080A3 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 02/12/2004 | WO2003054021A3 Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes |